Since its inception, Inspiration Research has successfully completed over 70 human clinical studies with leading global pharmaceutical and biotechnology companies including GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, Amgen, AstraZeneca, Nycomed, Schering-Plough, and Forest Laboratories.
Despite the number of medications available, a substantial number of patients continue to have uncontrolled or poorly controlled asthma and or COPD. At Inspiration Research Ltd, we work with all the leading pharmaceutical/biotechnology companies to examine the latest asthma therapies with patients. A vital part of that process is to conduct studies to demonstrate the efficacy and safety of the new therapies.
Studies vary in length, ranging from 6 months to 3 years. In each study, there are a set number of on-site study visits. We are located in downtown Toronto, near the intersection of Spadina Ave. and College St. The duration of each visit depends on the number of procedures as stated by the study protocol. At the first study visit, the visit schedule and the duration of each visit will be provided to study participants. Reimbursement is provided for out-of-pocket expenses, usually between $50 – $100, at the end of each visit.
If you are interested in getting involved in a clinical trial please reach out! We are happy to explain any current opportunities and the eligibility criteria.